STAR vs RELIANCE
Head-to-head DCF comparison · STRIDES PHARMA SCI LTD vs Reliance Industries
Model Favors
STAR shows a larger model margin of safety
Leads on 4 of 4model metrics · not investment advice
STAR
STRIDES PHARMA SCI LTD
General/Diversified
₹1,049
Below Fair ValueRELIANCE
Reliance Industries
Oil & Gas
₹1,328
Near Fair Value| Metric | STAR | RELIANCE |
|---|---|---|
| Verdict | Below Fair Value | Near Fair Value |
| YieldIQ Score | 78/100 | 30/100 |
| Fair Value | ₹1,370 | ₹1,266 |
| Current Price | ₹1,049 | ₹1,328 |
| Margin of Safety | +30.7% | -4.7% |
| Moat | Wide | Moderate |
| Piotroski F-Score | 8/9 | 6/9 |
| ROE | — | 6.9% |
| Debt / Equity | 0.66 | — |
| EV / EBITDA | 13.5× | 14.3× |
| Market Cap | ₹9,666 Cr | ₹17.98 Lakh Cr |
Run the full interactive analysis
DCF sliders, sensitivity tables, peer screens, watchlists — free to start.
Sign up free →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst.